Edition:
United Kingdom

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

1,929.95INR
5:55am BST
Change (% chg)

Rs-35.40 (-1.80%)
Prev Close
Rs1,965.35
Open
Rs1,956.75
Day's High
Rs1,957.00
Day's Low
Rs1,928.00
Volume
1,757
Avg. Vol
35,878
52-wk High
Rs2,469.00
52-wk Low
Rs1,578.30

Latest Key Developments (Source: Significant Developments)

India's Alkem Laboratories Dec Qtr Consol Profit Falls
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Alkem Laboratories Ltd ::DEC QUARTER CONSOL PROFIT 1.72 BILLION RUPEES VERSUS 2.33 BILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 17.40 BILLION RUPEES VERSUS 14.82 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 6 RUPEES PER SHARE.  Full Article

Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Alkem Laboratories Ltd ::SAYS U.S. FDA ISSUES EIR FOR CO'S MANUFACTURING FACILITY AT BADDI.SAYS ‍INSPECTION OF CO'S MANUFACTURING FACILITY AT BADDI HAS NOW BEEN CLOSED BY US FDA​.IN RESPONSE TO TWO FORM 483 OBSERVATIONS ISSUED BY FDA, CO SUBMITTED DETAILED CORRECTIVE AND PREVENTIVE ACTION PLAN TO REGULATOR.  Full Article

India's Alkem Laboratories Gets Shareholders' Nod For Appointment Of Sandeep Singh As MD
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Alkem Laboratories Ltd ::GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF SANDEEP SINGH AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF DHANANJAY KUMAR SINGH AS JOINT MD.  Full Article

India's Alkem Labs Sept-qtr consol profit rises
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Alkem Laboratories Ltd ::Sept quarter consol profit 3.27 billion rupees versus 2.88 billion rupees year ago.Sept quarter consol revenue from operations 18.65 billion rupees versus 16.38 billion rupees year ago.  Full Article

India's Alkem Laboratories CEO Prabhat Agrawal resigns
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Alkem Laboratories Ltd :Says Prabhat Agrawal resigns as CEO.  Full Article

India's Alkem Laboratories June-qtr consol net profit falls
Friday, 11 Aug 2017 

Aug 11 (Reuters) - Alkem Laboratories Ltd :June quarter consol net profit 637.8 million rupees versus profit of 2.43 billion rupees year ago.June quarter consol total income 13.25 billion rupees versus 15.09 billion rupees year ago.  Full Article

Alkem laboratories no form 483 issued by FDA after inspection at Taloja
Friday, 14 Jul 2017 

July 14 (Reuters) - Alkem Laboratories Ltd :Says US FDA had conducted an inspection at company's bioequivalence facility located at Taloja, India.Says at end of inspection at Taloja, no form 483 was issued.  Full Article

India's Alkem Laboratories March-qtr consol profit rises
Friday, 26 May 2017 

May 26 (Reuters) - Alkem Laboratories Ltd :March quarter consol profit 1.37 billion rupees versus profit 865.4 million rupees year ago.March quarter total income 12.76 billion rupees versus 12.52 billion rupees year ago.Recommended dividend of 9 rupees per share.  Full Article

Alkem Labs says USFDA closed inspection at API manufacturing unit at Ankaleshwar
Thursday, 30 Mar 2017 

Alkem Laboratories Ltd : Says inspection at company's API manufacturing facility located at Ankaleshwar has now been closed by US FDA . Says company had submitted a detailed corrective and preventive action (CAPA) plan to regulator within stipulated timelines . Says FDA issued an EIR for its API manufacturing facility at Ankaleshwar, India which was inspected in December 2016 .Says US FDA has reviewed CAPA and has found them acceptable.  Full Article

Alkem Labs says FDA finds 3 adverse observations at co's Baddi facility
Friday, 10 Mar 2017 

Alkem Laboratories Ltd : Says got 3 483 observations from USFDA .Says us fda inspection at alkem's baddi facility.  Full Article

India's Alkem Labs gets USFDA report about Amaliya unit

March 28 India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.